Merck & Co. Inc. (MRK) 13F Ownership Report (Q2 2026)

MRK ranks #30 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

3891 institutions disclose a position in MRK, but none treat it as a major bet — even Barrow Hanley Mewhinney & Strauss LLC, its most concentrated holder, allocates just 2.9% of its own portfolio to it.

Wealth Enhancement Advisory Services, LLC has added to its MRK position for two straight quarters, increasing it by $74.9M to reach $232.2M today.

Magnolia Capital Management LTD has trimmed its MRK position for two straight quarters, cutting it by $1.5M while still holding $1.2M.

MRK is up 0.5% today, and institutions have been net buyers of $61.8B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

MRK posted net income of $3.2B over the trailing twelve months.

• Profitable — net income of $3.2B over the trailing twelve months
• Revenue grew 4.6% year over year
• Net income declined year over year, from $16.4B to $3.2B
• Generated $16.5B in positive operating cash flow
• Current ratio of 1.54x — enough short-term assets to cover short-term liabilities
• Liabilities run x equity — a highly leveraged balance sheet worth noting